Source: Siliconangle
Generare Bioscience, a Paris-based biotech startup, raised €20 million ($23.3 million) in early-stage funding co-led by Alven and Daphni to develop AI systems that synthesize novel drug molecules. The company uses machine learning to generate previously unseen molecular data for accelerating drug development pipelines.